Medicus Pharma (NASDAQ:MDCX) Earns “Buy” Rating from D. Boral Capital
Medicus Pharma (NASDAQ:MDCX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They presently have a $27.00 target price on the stock. A number of other equities analysts have also recently weighed in on the company. D Boral Capital upgraded […]
Medicus Pharma (NASDAQ:MDCX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They presently have a $27.00 target price on the stock. A number of other equities analysts have also recently weighed in on the company. D Boral Capital upgraded […]
